Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2
暂无分享,去创建一个
D. Abraham | George Bou-Gharios | A. Leask | B. Poulet | P. Milner | I. Kanakis | L. Ramos-Mucci | C. Keenan
[1] Soichiro Ibaragi,et al. Expression and Role of IL-1β Signaling in Chondrocytes Associated with Retinoid Signaling during Fracture Healing , 2020, International journal of molecular sciences.
[2] A. Didangelos,et al. Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ , 2018, Annals of the rheumatic diseases.
[3] B. Perbal. The concept of the CCN protein family revisited: a centralized coordination network , 2018, Journal of Cell Communication and Signaling.
[4] B. Perbal. Once upon a time ...A special issue for the 10th anniversary of the Journal of Cell Communication and Signaling , 2018, Journal of Cell Communication and Signaling.
[5] P. Clegg,et al. Differential tissue specific, temporal and spatial expression patterns of the Aggrecan gene is modulated by independent enhancer elements , 2018, Scientific Reports.
[6] M. Brown,et al. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis , 2017, Arthritis Research & Therapy.
[7] M. Young,et al. WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis. , 2017, Osteoarthritis and cartilage.
[8] M. Takigawa,et al. CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function. , 2016, Bone.
[9] M. Takigawa,et al. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. , 2015, Clinical science.
[10] J. Saklatvala,et al. Generation of a mouse line harboring a bi‐transgene expressing luciferase and tamoxifen‐activatable creERT2 recombinase in cartilage , 2014, Genesis.
[11] F. Barry,et al. Mesenchymal stem cells in joint disease and repair , 2013, Nature Reviews Rheumatology.
[12] T. Yamashiro,et al. CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes , 2013, PloS one.
[13] T. Yamashiro,et al. Cartilage–Specific Over-Expression of CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Stimulates Insulin-Like Growth Factor Expression and Bone Growth , 2013, PloS one.
[14] S. Honsawek,et al. Plasma and synovial fluid connective tissue growth factor levels are correlated with disease severity in patients with knee osteoarthritis , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[15] C. Little,et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.
[16] M. Takigawa,et al. CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes. , 2008, Osteoarthritis and cartilage.
[17] V. Lefebvre,et al. L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer , 2008, Molecular and Cellular Biology.
[18] M. Barbe,et al. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF‐β1 to induce mesenchymal cell condensation , 2007, Journal of cellular physiology.
[19] S. Kondo,et al. Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. , 2006, Bone.
[20] F. Mooren,et al. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. , 2006, Arthritis and rheumatism.
[21] Kozo Nakamura,et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. , 2005, Osteoarthritis and cartilage.
[22] Changshan Wu,et al. Retinoid Signaling Regulates CTGF Expression in Hypertrophic Chondrocytes With Differential Involvement of MAP Kinases , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] H. Inoue,et al. Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. , 2004, Osteoarthritis and cartilage.
[24] Y. Tabata,et al. Regeneration of Defects in Articular Cartilage in Rat Knee Joints by CCN2 (Connective Tissue Growth Factor) , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] B. Perbal. CCN proteins: multifunctional signalling regulators , 2004, The Lancet.
[26] B. Yoon,et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.
[27] M. Takigawa,et al. Role of CTGF/HCS24/ecogenin in skeletal growth control , 2003, Journal of cellular physiology.
[28] H. Inoue,et al. Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. , 2002, Bone.
[29] S. Kondo,et al. CTGF/Hcs24, a hypertrophic chondrocyte‐specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes , 2002, Journal of cellular physiology.
[30] H. Yatani,et al. Regulatory mechanism of human connective tissue growth factor (CTGF/Hcs24) gene expression in a human chondrocytic cell line, HCS-2/8. , 2001, Journal of biochemistry.
[31] S. Yoshida,et al. Retinoic Receptor Signaling Regulates Hypertrophic Chondrocyte-specific Gene Expression , 2018, In Vivo.
[32] A. Pitsillides,et al. Characterizing a novel and adjustable noninvasive murine joint loading model. , 2011, Arthritis and rheumatism.
[33] M. Takigawa,et al. Effects of CTGF/Hcs24, a Product of a Hypertrophic Chondrocyte-Specific Gene, on the Proliferation and Differentiation of Chondrocytes in Culture1. , 2000, Endocrinology.